Fenwick represented Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery ...

NEW YORK — Fenwick announced today that Roger Cohen has joined the firm as a partner in its New York office and healthcare regulatory practice.

Fenwick today announced the election of five lawyers to its partnership, effective January 1, 2027.

Fenwick represented Alta, an AI-powered fashion styling platform, in its $20 million Series A funding. The round was led by ...

Fenwick represented Qualitate, builder of the first continuous intelligence system for primary research, in its $25 million ...

Fenwick has submitted a comment letter responding to the SEC’s request for creative ideas to modernize the initial public offering process. The letter addresses frictions that may discourage companies ...

Each year, Fenwick publishes the SV 150 List and a Proxy Season report comparing stockholder voting results between SV 150 companies and companies comprising the Standard & Poor’s 100 Index.

LA Tech Week made one thing clear: hard tech is now a core part of Tech Week. About one in seven events on the LA calendar addressed the topic, and Fenwick hosted and joined several of them. Here are ...

Fenwick represented Workday, Inc. (NASDAQ: WDAY), the trusted agentic platform for HR, finance, and IT, in its underwritten, registered public offering of $2.5 billion aggregate principal amount of ...

206-389-4553 arose@fenwick.com Print Resume Download Contact Card LinkedIn Amanda is a recognized, focused and innovative leader in the capital markets and life sciences space. Amanda is a strategic ...

Nov.–Dec. 2026: Lame-duck session; the KIDS Act, GUARD Act, and the Senate Commerce Committee’s kids’ online safety and chatbot bills await Senate action, and House and Senate negotiators may ...

Fenwick represented IMIO, the pioneering manufacturer of a new generation of dependable agricultural biologicals, in its $12 million Seed funding. The round was led by Sofinnova Partners with ...